Repository logo
  • English
  • Español
  • Log In
    or
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • Explore repository
  • English
  • Español
  • Log In
    or
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Wales, William"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Publication
    When entrepreneurial rhetoric meets strict regulations: Implications for the valuation of health science firms
    (Blackwell Publishing Ltd, 2021) Wang, Taiyuan; Malik, Sumeet; Wales, William; https://ror.org/02jjdwm75
    Research Summary: Health science firms have long product development horizons and need regulatory approval for market entry. In communicating with investors,they may use entrepreneurial orientation (EO) rhetoric to emphasize their strategic and behavioral commitment to product innovation and market entry. However,because EO rhetoric constitutes a soft-information signal rather than evidence of substantive commitment,investors may suspect firm insiders using such rhetoric of impression management. The solution,we argue,is EO rhetoric sustained over time,which produces more reliable information for investors—in contrast to occasional increases in EO rhetoric,which invite skeptical scrutiny. Nevertheless,investors' potential concerns regarding changes in EO rhetoric can be mitigated by concurrent hard-information signals that carry signaling costs or penalty costs for false signaling. Managerial Summary: Entrepreneurial orientation (EO) rhetoric can reduce information asymmetry between managers and investors. In strictly regulated contexts such as health science industries,using such rhetoric may be challenging. For firms embracing entrepreneurial strategies and behaviors,maintaining EO rhetoric over time is critical to overcoming skepticism that it is merely “cheap talk.” For investors,this study also suggests that health science firms maintaining higher EO rhetoric over time deserve higher valuations,given the variety of benefits an EO can have for health science firms. If a health science firm aims to ramp up its EO rhetoric,managers should be aware that investors may interpret the increase as impression management and should confront this interpretation head-on—for instance,by simultaneously increasing entry commitment or corporate social responsibility. © 2021 The Authors. Strategic Entrepreneurship Journal published by John Wiley & Sons,Ltd. on behalf of Strategic Management Society.
IE Repository
  • Legal Advise
  • Privacy Policy
  • Cookies Policy
Additional Resources
  • IE University Library
  • Contact Us
Contact
  • +34 91 568 96 00
  • openaccess@ie.edu

IE Repository copyright © 2002-2025